Send me a link:

*Text messaging rates may apply.

 Dow Up0.13% Nasdaq Down0.10%

Adamis Pharmaceuticals Corporation (ADMP)

-NasdaqCM
3.93 Down 0.09(2.12%) 3:58PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development379  208  195  225  
Selling General and Administrative1,335  776  762  515  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (1,714) (984) (957) (740)
Income from Continuing Operations
Total Other Income/Expenses Net307  753  3,703  102  
Earnings Before Interest And Taxes(1,407)(231)2,746  (638)
Interest Expense145  5,298  2,778  405  
Income Before Tax(1,552)(5,529)(32)(1,042)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(1,552)(5,529)(32)(1,042)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (1,552) (5,529) (32) (1,042)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (1,552) (5,529) (32) (1,042)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.